Literature DB >> 8836791

Effect of digital rectal examination on plasma prostate-specific antigen (PSA).

S Dutkiewicz1, K Stepień, A Witeska.   

Abstract

UNLABELLED: Presented are results of determination of plasma PSA before, 1 and 24 hours and 3 weeks after digital rectal examination (DRE) in 130 patients with prostatic adenoma (BPH). Mean pre-examination PSA level was 8.5 ng/ml (max. 27.0 ng/ml, min. 0.3 ng/ml, SD = 6.2). PSA rose at 1 and 24 hr. post-DRE: 9.4 ng/ml (max. 28.9 ng/ml, min. 0.5 ng/ml, SD = 6.7) and 10.7 ng/ml (max. 28.0 ng/ml, min. 0.5 ng/ml, SD = 7.9), respectively.
CONCLUSION: in patients with prostatic adenoma DRE is followed by a rise in plasma PSA, which returns almost to baseline values by 3 weeks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836791     DOI: 10.1007/bf02550863

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

Review 1.  Prostatic specific antigen.

Authors:  R J Shearer
Journal:  Br J Urol       Date:  1991-01

2.  Measurement of prostate-specific antigen as a screening test for prostate cancer.

Authors: 
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

Review 3.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

4.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Authors:  W J Catalona; D S Smith; T L Ratliff; K M Dodds; D E Coplen; J J Yuan; J A Petros; G L Andriole
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

5.  The prognostic value of prostate-specific antigen and prostatic acid phosphatase in serum of patients with prostate cancer after orchidectomy.

Authors:  S Dutkiewicz; B Stawarz; A Lypka; H Zieliński
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

6.  [Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma].

Authors:  S Dutkiewicz; K Stepień; A Witeska
Journal:  Wiad Lek       Date:  1992-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.